Table 3.
Treatment cycle outcomes for PPCOS II participants who had unilateral occlusion on HSG
| Outcome | Unilateral occlusion on HSG (N = 32) | Both tubes patent on HSG (N = 185) | P value* |
|---|---|---|---|
| Ovulation | 28/32 (87.5) | 159/185 (86.0) | 0.814 |
| Conception | 11/32 (34.4) | 76/185 (41.1) | 0.475 |
| Clinical pregnancy | 8/32 (25.0) | 60/185 (32.4) | 0.403 |
| Pregnancy loss | 4/32 (12.5) | 24/185 (13.0) | 0.941 |
| First trimester lossa | 3/32 (9.4) | 22/185 (11.9) | 0.681 |
| Ectopicb | 2/32 (6.3) | 4/185 (2.2) | 0.193 |
| Live birth | 7/32 (21.9) | 52/185 (28.1) | 0.464 |
| Days to pregnancy | |||
| N | 11 | 71 | |
| Mean ± SD | 89.5 ± 53.2 | 92.0 ± 46.1 | 0.867 |
*P value for significance of difference between SIS vs. HSG groups only
aPregnancy loss in the first 12 weeks
bIncludes seven ectopic pregnancies, one heterotopic pregnancy, and two pregnancies of unknown location